Search
for
Sort by
Research 301–330 of 1000+
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Common Causes of Hair Loss
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Alopecia Areata: A Comprehensive Review of Pathogenesis, Diagnosis, and Emerging Therapeutics
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- SDRIFE Induced by Tofacitinib
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Hair loss disorders (alopecias)
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Androgenetic alopecia: An update
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Baricitinib: A Review in Severe Alopecia Areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study